Why the study?
Does sirolimus-eluting VElocity balloon-expandable stent prevent neointimal hyperplasia in patients with de novo native coronary artery Lesions?
Does sirolimus-eluting VElocity balloon-expandable stent prevent neointimal hyperplasia in patients with de novo native coronary artery Lesions?
Sirolimus-eluting stents effectively prevent neointimal hyperplasia without causing edge effects or altering plaque burden behind the struts.
Answers are grounded in this paper and cite their sources.
Favors sirolimus-eluting stents for de novo coronary lesions to curb restenosis; confirms antiproliferative benefit in randomized data.
Sirolimus-eluting stents are effective in preventing neointimal hyperplasia without creating edge effect and without affecting the plaque burden behind the struts.
No takes yet. Share an insight, caveat, or question.
Serruys et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: